Skip to content
Review Open access

Exploring the Anticancer Potential of Plant, Marine, and Synthetic Glycosides: A Comprehensive Review

Oct 2026 · Biomolecules · Vol 16, pp. 1493 · 0 citations · 219 references
Medicine

TL;DR

Overall, glycosides represent promising anticancer scaffolds, but systematic optimization of potency, selectivity, stability, bioavailability, and safety is required to facilitate their translation into clinically useful therapeutics.

Abstract

Despite advances in pharmaceutical and technological development, cancer continues to be a life-threatening illness globally. In addition to other specialized procedures, radiotherapy, chemotherapy, and surgery are methods used to treat cancer. However, in recent years, natural products have either been used as food supplements or complementary medicine in the management and treatment of cancer. Natural products are the secondary metabolites present in the cells of medicinal plants, microbes, and marine organisms. Glycosides are a naturally occurring class of metabolites with exceptional therapeutic value and clinical efficacy. The structure of all glycosides is similar; it consists of two parts: a hydrophilic glycone unit made up of one or more sugar components, and a lipophilic aglycone unit. Over the past few years, the potential anti-cancer properties of several natural and synthetic glycosides have been investigated. In this review, we compile and analyze 224 naturally occurring glycosides from plant and marine sources, along with more than 40 synthetic glycosides, that exhibit anticancer properties. Reported anticancer activities span a wide potency range and involve multiple mechanisms, including apoptosis, cell-cycle arrest, oxidative stress, mitochondrial dysfunction, inhibition of PI3K/AKT, MAPK, STAT3, Wnt/β-catenin, and Na+/K+-ATPase signaling, as well as suppression of migration and invasion. Several compounds show potency comparable to or exceeding standard chemotherapeutics under matched assay conditions: for example, an epigallocatechin-3-O-gallate derivative inhibited MDA-MB-231 cells at an IC50 of 3.27 ± 0.18 µM versus 5.20 ± 0.89 µM for capecitabine, and a synthetic N-glycosyl heterocycle (compound 479a) outperformed erlotinib against HepG-2 and HCT-116 cells (IC50 = 1.64 ± 0.11 and 5.00 ± 0.51 µM vs. 2.07 ± 0.07 and 5.14 ± 0.33 µM). Other studies reported glycosides with activities comparable to or greater than reference agents such as capecitabine, tamoxifen, and erlotinib. Despite these promising findings, the evidence remains predominantly preclinical, with substantial limitations in normal-cell selectivity, standardized cytotoxicity assessment, pharmacokinetic characterization, and in vivo and clinical validation. Overall, glycosides represent promising anticancer scaffolds, but systematic optimization of potency, selectivity, stability, bioavailability, and safety is required to facilitate their translation into clinically useful therapeutics.

Read PDF

Similar papers

Review Open access Sep 2026

PHYTOCHEMICALS FROM AYURVEDIC HERBS: MOLECULAR AND GENETIC BASIS OF ANTICANCER ACTIVITY — MECHANISMS, MOLECULAR TARGETS, AND THERAPEUTIC PERSPECTIVES

Key Ayurvedic phytochemicals-based nature, such as curcumin, withaferin A, nimbolide, berberine, and eugenol, are examined, detailing their mechanisms in inhibiting cancer, including apoptosis induction, cell cycle arrest, as well as tumor angiogenesis suppression.

Y. Narkhede, N. V. Borse · 0 citations
Review Sep 2026

Phytochemical Horizons in Anticancer Drug Discovery: From Lead Molecules to Clinical Prospects

In the present day, there is a great concern about the second deadliest disease, cancer. An enormous number of mortalities rate is increasing every year because of cancer despite a few inter-cessions accessible. Advancements in potency with fewer side effects make anticancer treatment a promising area of drug devel...

M. Ramu, S. Gunturu, S. Metri et al. · 0 citations
Review Oct 2026

Innovative Applications of The Coumarin Scaffold In Medicinal Chemistry: Design Strategies and Therapeutic Potential.

Coumarin (1,2-benzopyran-2-one) is a naturally occurring benzopyrone that serves as the core scaffold of a diverse class of bioactive compounds produced by plants, fungi, and certain bacteria. Coumarin derivatives exhibit a broad spectrum of biological activities, including anticoagulant, antioxidant, anti-inflammatory...

M. Sharma, P. Talwan, Vikrant Dalwal et al. · 0 citations
Review Oct 2026

Natural Products as Promising Therapeutic Agents in Cancer Management.

Natural products have historically served as an indispensable source of anticancer agents and continue to inspire the development of novel therapeutics for cancer management. Despite significant advances in chemotherapy, radiotherapy, immunotherapy, and targeted therapies, treatmentassociated toxicity, multidrug resist...

J. Dash, Itishree Bindhani, G. Pattnaik · 0 citations
Review Open access Sep 2026

Coumarin derivatives as promising anticancer drugs: a comprehensive review from synthesis to anticancer applications

This article summarizes the classical synthetic routes for the coumarin core and modern synthetic strategies for various coumarin derivatives, such as transition-metal-catalyzed cross-coupling, multicomponent and one-pot reactions, click chemistry, green and biocatalytic protocols, and metal complexation, and discusses...

An-Di Suo, Meng-Jia Xu, Ming Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.